Agenda
8:30 AM — 12:00 PM
#22: Global Reimbursement Systems: A Market Access Perspective8:30 AM — 12:00 PM
#23: A Device Primer: 510(k)s, PMAs, IDEs8:30 AM — 12:00 PM
#25: Leadership: How to Organize and Lead People in Group Work9:00 AM — 5:00 PM
#50: Understanding and Navigating the Regulatory System in China9:00 AM — 5:00 PM
#51: Quality Oversight of CROs-Clinical Vendors9:00 AM — 5:00 PM
#52: Regulatory Affairs for Biologics9:00 AM — 5:00 PM
#53: Clinical Statistics for Nonstatisticians9:00 AM — 5:00 PM
#54: Art of Writing a Clinical Overview9:00 AM — 5:00 PM
#55: Overview of Drug Development9:00 AM — 5:00 PM
#56: Risk Communications9:00 AM — 3:45 PM
#57: Preparing for a US FDA Advisory Committee Meeting1:00 PM — 4:30 PM
#30: Analysis of Safety Data from Clinical Trials1:00 PM — 4:30 PM
#34: Fourteen Steps from Research to Development8:30 AM — 10:00 AM
Opening Plenary11:00 AM — 12:30 PM
CBER Town Hall11:00 AM — 12:30 PM
Clinical Trials on Trial: Potential Legal Liability Arising from Clinical Trials11:00 AM — 12:30 PM
Electronic Health Records (EHRs) in Signal Detection and Evaluation11:00 AM — 12:30 PM
Evaluation and Selection of the Optimal Endpoints for Clinical Studies11:00 AM — 12:30 PM
Global Symposium11:00 AM — 12:30 PM
Hot Topics in Statistics: Working Together Effectively to Transform Our Science11:00 AM — 12:30 PM
How Can Translational Medicine Fill the Gaps in Life Sciences Industries?11:00 AM — 12:15 PM
Innovative Partnerships for mHealth11:00 AM — 12:30 PM
Managing Data at Arms' Length: China11:00 AM — 12:30 PM
Narrative Medicine and Pharmacovigilance11:00 AM — 12:30 PM
Next Generation Medical Information Call Center11:00 AM — 12:30 PM
Pediatric Drug Development: A New Paradigm Under FDASIA11:00 AM — 12:30 PM
Portfolio Management Symposium11:00 AM — 12:30 PM
Practical Considerations for GCP Audits in a Risk-based Environment11:00 AM — 12:30 PM
Regulatory Environment in the US: CDRH Panel Discusses What's on the Horizon11:00 AM — 12:30 PM
Shape Your Cost with Hard and Soft Coverage Analysis Trends11:00 AM — 12:30 PM
Stage Gate Decision-making Workshop, Part 1 of 211:00 AM — 12:30 PM
The State of Clinical Outsourcing: Managing Risk in Outsourced Clinical Trials11:00 AM — 12:30 PM
Vendor Management Using Quality by Design and Risk Management Strategies2:30 PM — 4:00 PM
Bridging the Gap Between Strategy and Execution2:30 PM — 4:00 PM
Cooperation Among Regulators: Impact on Stakeholders2:30 PM — 4:00 PM
Effectiveness Checks in the Clinical Research Setting2:30 PM — 4:00 PM
Global Clinical Trials: The Role of Emerging Markets2:30 PM — 4:00 PM
Key Multiplicity Issues in Clinical Trials2:30 PM — 4:00 PM
Legal Jeopardy from the Conduct of Clinical Trials2:30 PM — 4:00 PM
Quality Risk Management: An Old Hat?2:30 PM — 4:00 PM
Stage Gate Decision-making Workshop, Part 2 of 22:30 PM — 4:00 PM
That Awkward Stage: Transition from Paper Trial Master File to eTMF2:30 PM — 4:00 PM
The Secret of Stellar Careers: Serendipity plus Planning = Success8:00 AM — 9:30 AM
A Regulatory Perspective of Biosimilars in Emerging Markets8:00 AM — 9:30 AM
Biomarkers for Drug Development: How Are We Dealing with the Challenges?8:00 AM — 9:30 AM
Careers Beyond Project and Portfolio Management: A Panel Discussion8:00 AM — 9:30 AM
Ethical Issues in Clinical Trials8:00 AM — 9:30 AM
Expediting Drug Development and Review for Serious Conditions8:00 AM — 9:30 AM
GCP and Inspection Readiness8:00 AM — 9:30 AM
Innovation and Evolution Within the Medical Science Liaison Role8:00 AM — 9:30 AM
Making CRO-Sponsor Partnerships Work: Executive Roundtable8:00 AM — 9:30 AM
Moving to a Standards-based, Agile Clinical Development Lifecycle8:00 AM — 9:30 AM
Pharmaceuticals and Medical Devices Agency (PMDA) Town Hall8:00 AM — 9:30 AM
Postmarket Surveillance Issues for Medical Devices8:00 AM — 9:30 AM
Prescription Drug Marketing Regulatory Primer8:00 AM — 9:30 AM
Research Advances for Rare Diseases and Orphan Products8:00 AM — 9:30 AM
The Regulatory Writing Game Show8:00 AM — 9:30 AM
The Thorough QT Study: Isn’t There a Better Way to Do This?10:15 AM — 11:45 AM
Achieving Innovative Technology Results10:15 AM — 11:45 AM
Advanced Presentation Skills10:15 AM — 11:45 AM
Big Data: Impact on Innovation10:15 AM — 11:45 AM
Circulating Tumor Cells (CTCs) as a Biomarker Approach in Oncology10:15 AM — 11:45 AM
DIA 2013 Student Forum: Getting a Job and Developing a Career10:15 AM — 11:45 AM
Domestic and Global Trends in Clinical Trial Budgeting10:15 AM — 11:45 AM
EU Update: PROTECT and EnCePP10:15 AM — 11:45 AM
FDA Enforcement Update: Advertising and Promotion10:15 AM — 11:45 AM
Statistical Considerations When Developing Antibacterial Treatments10:15 AM — 11:45 AM
Strategies for the Development and Registration of Antibody Drug Conjugates10:15 AM — 11:45 AM
The Aging Population: Approaches to Ensure Safety and Efficacy1:45 PM — 3:15 PM
Approaches to Quality Risk Management: Understanding What Matters1:45 PM — 3:15 PM
Convergence in Regulatory Science Across the Strait1:45 PM — 3:15 PM
Drug Development for Commercial Success1:45 PM — 3:15 PM
Electronic Submissions in PDUFA V1:45 PM — 3:15 PM
Enrollment Analytics: Moving Beyond the Funnel1:45 PM — 3:15 PM
First-in-Human Studies: How Much Complexity Is Too Much?1:45 PM — 3:15 PM
GCP Risk-based Monitoring1:45 PM — 3:15 PM
Human Abuse Liability Testing in CNS Drug Development1:45 PM — 3:15 PM
Innovative Computerized System Validation and Auditing1:45 PM — 3:15 PM
Looking Closer into the Utility of Adaptive Approaches1:45 PM — 3:15 PM
Quality Assurance for Signal Detection Programs1:45 PM — 3:15 PM
Taking the Measure of Metrics1:45 PM — 3:15 PM
US and EU Regulatory Update of Clinical Trial Disclosure4:00 PM — 5:30 PM
Advanced Presentation Skills4:00 PM — 5:30 PM
Analysis Data Standards: Developing, Applying, Submitting and Reviewing4:00 PM — 5:30 PM
Approaches to Risk-based Monitoring4:00 PM — 5:30 PM
Development for Rare Disease Treatments4:00 PM — 5:30 PM
Evaluating Sites for Optimum Site Selection and Performance4:00 PM — 5:30 PM
Four Ways to Accelerate Clinical Portfolio Strategy4:00 PM — 5:30 PM
GCPs in Emerging Countries4:00 PM — 5:30 PM
Labeling and Patient Medical Information (PMI)4:00 PM — 5:30 PM
Lessons Learned from the EMA-FDA Quality by Design (QbD) Pilot4:00 PM — 5:30 PM
Optimizing the Transition from Preclinical to Clinical Research4:00 PM — 5:30 PM
Product Communications in the Preapproval Phase4:00 PM — 5:30 PM
Protocol Trends and Strategies for Quality4:00 PM — 5:30 PM
Risk Management in the US, EU and Japan: The Challenges of Diversity4:00 PM — 5:30 PM
The Evolving Clinical Trial Disclosure Global Landscape4:00 PM — 5:30 PM
Where Research, Medicine and Care Converge: A CMO Roundtable Discussion5:30 PM — 7:30 PM
Movie Documentary: RARE8:00 AM — 9:30 AM
Clinical Trial Design for Optimal Patient Recruitment and Retention8:00 AM — 9:30 AM
Collaborating to Streamline Drug Development: Are We Making Progress?8:00 AM — 9:30 AM
Cost Management for Global Drug Development Projects8:00 AM — 9:30 AM
Current Developments in the Automated NDA Field Alert Reporting Project8:00 AM — 9:30 AM
FDA-Health Canada Regulatory Cooperation Council (RCC) Town Hall8:00 AM — 9:30 AM
How to Prepare for Meetings, Both Internal and with the FDA8:00 AM — 9:30 AM
How Will Risk-adapted Clinical Trials Be Inspected?8:00 AM — 9:30 AM
Molecular Imaging: Utilizing It as an Effective Drug Development Tool8:00 AM — 9:30 AM
Pharmacovigilance Update for Japan, Developing Asia and Latin America8:00 AM — 9:30 AM
Tethering the Channels of Scientific and Medical Content8:00 AM — 9:30 AM
Using Legislation to Advance Regulatory Science: "I'm Just a Bill..."10:15 AM — 11:45 AM
Advancing Alzheimer’s Innovation: A Call to Action10:15 AM — 11:45 AM
Advancing Endpoint Adjudication10:15 AM — 11:45 AM
Drug Shortages: Causes, Current State and Path Forward10:15 AM — 11:45 AM
EDC Insights: Before, During, and After10:15 AM — 11:45 AM
Enforcement Trends and Public Policy: Lessons Learned and Practices to Follow10:15 AM — 11:45 AM
Innovative Strategies for Evolving Sponsor, CRO and Site Alliances10:15 AM — 11:45 AM
Study Startup Symposium10:15 AM — 11:45 AM
Successful Mentoring Relationships12:15 PM — 1:00 PM
SAS Innovation Theater: Picture This: Bringing Clinical Data to Life1:45 PM — 3:15 PM
Challenges and Strategic Approaches to Biosimilar Development1:45 PM — 3:15 PM
Clinical Trial Simulations and Modeling1:45 PM — 3:15 PM
Cloud Technology for Decision Makers: What’s Real and How to Validate It1:45 PM — 3:15 PM
FDASIA Patient Provisions: One Year Later1:45 PM — 3:15 PM
Submitting an Abstract for the DIA 2014 50th Annual Meeting1:45 PM — 3:15 PM
The Science of Compliance1:45 PM — 3:15 PM
Transition from SME to Subject Matter Educator Extraordinaire (SMEE)!1:45 PM — 3:15 PM
Using Big Data to Design Smarter Studies1:45 PM — 3:15 PM
Using Competence Models to Drive High Quality Drug Project Management3:30 PM — 4:30 PM
SCOTUS DNA Patent Ruling: Implications for the Industry4:00 PM — 5:30 PM
Challenges for Stable Supply of Drugs and International Cooperation4:00 PM — 5:30 PM
Data Standards Strategy4:00 PM — 5:30 PM
Ensuring Patient-centered Care: Partnering with Patient Advocacy4:00 PM — 5:30 PM
Ethical Issues in Clinical Trials4:00 PM — 5:30 PM
Global Pediatric Development: Next Steps4:00 PM — 5:30 PM
Herbal-induced Liver Injury (HILI): How That May Impact Rx Benefit-Risk4:00 PM — 5:30 PM
Latin America Town Hall4:00 PM — 5:30 PM
Overcoming Unique Challenges of Pediatric Studies4:00 PM — 5:30 PM
Partnering and Outsourcing Challenges in India: The New Paradigm Shifts4:00 PM — 5:30 PM
Pharmacometric Methods: Essential for Optimal Drug Development Strategy4:00 PM — 5:30 PM
Rescuing and Repurposing Drugs: Challenges and Opportunities5:30 PM — 7:30 PM
Movie Documentary: Here.Us.Now.9:00 AM — 10:30 AM
CDER Town Hall: Part 1 of 29:00 AM — 10:30 AM
Changing Landscape of IT in the Pharmaceutical Industry9:00 AM — 10:30 AM
Coding with Confidence9:00 AM — 10:30 AM
eDM From Three Sponsors9:00 AM — 10:30 AM
eSource Symposium9:00 AM — 10:30 AM
Hot Topics in Clinical Supplies9:00 AM — 10:30 AM
Medical Devices Global Symposium9:00 AM — 10:30 AM
Mobile Learning and Social Media Symposium9:00 AM — 10:30 AM
Parents as Partners: Engaging Caregivers for Pediatric Trials9:00 AM — 10:30 AM
Postapproval Change Management: Challenges and Opportunities9:00 AM — 10:30 AM
Strategic Partnerships: Emerging Models and Their Impact on Drug Development10:45 AM — 12:15 PM
Bayesian Methods in Medical Product Development and Comparative Effectiveness10:45 AM — 12:15 PM
CDER Town Hall: Part 2 of 210:45 AM — 12:15 PM
Cultural Awareness and Collaboration10:45 AM — 12:15 PM
Emerging Electronic Tools in Cardiovascular Outcomes Studies10:45 AM — 12:15 PM
Implementing a Paperless Trial for Phase 3: A Biotech’s Lessons Learned10:45 AM — 12:15 PM
Protocol Deviations: Avoidable Problems or an Unavoidable Risk10:45 AM — 12:15 PM
The Importance of Country Selection in Clinical Study Design10:45 AM — 12:15 PM
Transforming Relationships to Adapt to Evolving Organizational Strategic Goals10:45 AM — 12:15 PM
What's the Point? Can Point of Care Devices Enhance Clinical Trials?8:00 AM — 5:00 PM
Have an account?